Methamphetamine use disorder (MUD) remains one of the most underserved disorders in addiction medicine, largely because there are no FDA-approved medications for its treatment—yet. The 2024 National ...
Extended-release injectable naltrexone combined with extended-release oral bupropion (NTX + BUPN) for moderate or severe methamphetamine use disorder was associated with a significant decrease in use ...
A placebo-controlled trial showed that use of the antidepressant mirtazapine in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder. There were no ...
Though overdose deaths continue to surge, there is no approved medication to treat methamphetamine use disorder. Now, an experimental two-drug therapy has yielded promising results, UCLA researchers ...
Methamphetamine (MA) use disorder poses a significant public health challenge, particularly given the rise in MA-involved overdoses over the past decade. Despite the severity of this issue, there is ...
A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment, UCLA-led research suggests.
About The Study: In this parallel-group randomized clinical trial, the generic tetracyclic antidepressant mirtazapine delivered in routine clinical practice reduced methamphetamine use in adults with ...
Dr. Curtis Bone is an addiction medicine physician with Be Well Texas. (Copyright 2024 by KSAT - All rights reserved.) SAN ANTONIO – Recovery is a long road for ...
The American West has seen the biggest surge of cardiomyopathy-associated hospital admissions among methamphetamine users, based on 13 years of the latest available hospital admission data. The ...
The obstetrics staff was surprised the first time it happened in June 2025. A pregnant woman who was dependent on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results